FRANCES ARNOLD - 26 Feb 2026 Form 4 Insider Report for Generate Biomedicines, Inc. (GENB)

Role
Director
Signature
/s/ Michael Wolf, Attorney-in-Fact
Issuer symbol
GENB
Transactions as of
26 Feb 2026
Net transactions value
$0
Form type
4
Filing time
02 Mar 2026, 18:02:28 UTC
Previous filing
30 Jan 2026
Next filing
04 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
ARNOLD FRANCES Director GENERATE BIOMEDICINES, INC., 101 SOUTH STREET, SUITE 900, SOMERVILLE /s/ Michael Wolf, Attorney-in-Fact 02 Mar 2026 0001665419

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GENB Stock Option (Right to Buy) Award $0 +29,561 $0.000000 29,561 26 Feb 2026 Common Stock 29,561 $16.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option shall vest in full on February 19, 2027, subject to the Reporting Person's continued service on such vesting date.